Atlas Venture Associates XI, LP

Insider profile

Atlas Venture Associates XI, LP's trades of Dyne Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-06 2026-05-06 PrS Proposed sale
76,104
138.28
US$3,756,531
76,104 138.28 US$3,756,531
2026-05-05 2026-05-05 PrS Proposed sale
2,698
405.75
US$622,114
2,698 405.75 US$622,114
2026-05-04 2026-04-29 PrS Proposed sale
69,383
284.83
US$2,540,539
69,383 284.83 US$2,540,539
2026-04-28 2026-04-28 PrS Proposed sale
1,171
18.04
US$21,125
1,171 18.04 US$21,125
2026-04-27 2026-04-27 PrS Proposed sale
894
18.26
US$16,324
894 18.26 US$16,324
2026-04-24 2026-04-24 PrS Proposed sale
710
18.90
US$13,419
710 18.90 US$13,419
2026-04-23 2026-04-23 PrS Proposed sale
377
19.67
US$7,416
377 19.67 US$7,416
2026-04-22 2026-04-22 PrS Proposed sale
1,485
19.21
US$28,527
1,485 19.21 US$28,527
2026-04-21 2026-04-21 PrS Proposed sale
1,413
20.02
US$28,288
1,413 20.02 US$28,288
2026-04-20 2026-04-20 PrS Proposed sale
1,401
20.41
US$28,594
1,401 20.41 US$28,594